In a preliminary study, we also observed a reduction of circulating plasma TAGLN, as measured by mass spectrometry, in patients with CAD in comparison to controls (data not shown), but additional studies will be needed to further investigate this issue. Here, TAGLN is linked to coronary artery disorder.